Prophylactic Cranial Irradiation and Survival in Limited-Stage SCLC: A Multicenter Real-World Analysis From the Canadian SCLC Database (CASCADE)
Rattachement africain : ca. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Introduction: Prophylactic cranial irradiation (PCI) is frequently used in limited-stage SCLC (LS-SCLC) to reduce the risk of brain failure after a response to chemoradiation. However, its benefit remains debated in the modern era, with improved imaging and surveillance techniques and evolving systemic therapy options. We conducted a nationwide real-world study using the CASCADE database to evaluate the impact of PCI on survival outcomes in patients with LS-SCLC. Methods: We analyzed patients from CASCADE, a Canadian multi-institutional database that includes patients with SCLC from nine institutions. Eligible patients with pathologically confirmed LS-SCLC diagnosed between 2004 and 2022 were included. We compared outcomes between patients receiving PCI and those omitting this treatment. Overall survival and progression-free survival were assessed using Kaplan-Meier methods and Cox proportional hazards models. Brain metastasis incidence was evaluated in a predefined subgroup of patients with data on brain failure outcomes using competing-risk methods, and a predefined subgroup analysis was conducted in patients with baseline brain magnetic resonance imaging. Results: < 0.0001). With multivariable analysis, PCI remained independently associated with improved overall survival (hazard ratio = 0.70, 95% confidence interval: 0.57-0.86) and progression-free survival (hazard ratio = 0.61, 95% confidence interval: 0.50-0.74). Patients treated with PCI had a reduced incidence of brain metastasis. Notably, this improvement in survival was observed in patients who received baseline brain magnetic resonance imaging. Conclusions: In this large, multi-institutional, real-world cohort, PCI for the treatment of LS-SCLC was associated with improved overall survival, likely driven in part by a reduced brain metastasis risk. These findings support the continued role of PCI and highlight the need for further study in the modern imaging era.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Prophylactic Cranial Irradiation and Survival in Limited-Stage SCLC: A Multicenter Real-World Analysis From the Canadian SCLC Database (CASCADE)
- Date Crossref
- 01/08/2026
- Éditeur
- Elsevier BV
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.